Literature DB >> 21551011

PKB signaling and atrogene expression in skeletal muscle of aged mice.

Megan Gaugler1, Alicia Brown, Erin Merrell, Maria DiSanto-Rose, John A Rathmacher, Thomas H Reynolds.   

Abstract

The purpose of this study was to determine if PKB signaling is decreased and contractile protein degradation is increased in extensor digitorum longus (EDL) and soleus (SOL) muscles from middle-aged (MA) and aged (AG) mice. We also examined the effect of age on atrogene expression in quadriceps muscle. PKB activity, as assessed by Thr(308) and Ser(473) phosphorylation, was significantly higher in EDL and SOL muscles from AG than MA mice. The age-related increase in PKB activity appears to be due to an increase in expression of the kinase, as PKB-α and PKB-β levels were significantly higher in EDL and SOL muscles from AG than MA mice. The phosphorylation of forkhead box 3a (FOXO3a) on Thr(32), a PKB target, was significantly higher in EDL muscles from AG than MA mice. The rate of contractile protein degradation was similar in EDL and SOL muscles from AG and MA mice. Atrogin-1 and muscle-specific RING finger protein 1 (MuRF-1) mRNA levels did not change in muscles from AG compared with MA mice, indicating that ubiquitin-proteasome proteolysis does not contribute to sarcopenia. A significant decrease in Bcl-2 and 19-kDa interacting protein 3 (Bnip3) and GABA receptor-associated protein 1 (Gabarap1) mRNA was observed in muscles from AG compared with MA mice, which may contribute to age-related contractile dysfunction. In conclusion, the mechanisms responsible for sarcopenia are distinct from experimental models of atrophy and do not involve atrogin-1 and MuRF-1 or enhanced proteolysis. Finally, a decline in autophagy-related gene expression may provide a novel mechanism for impaired contractile function and muscle metabolism with advancing age.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21551011      PMCID: PMC3137534          DOI: 10.1152/japplphysiol.00175.2011

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  34 in total

1.  Atrophy-related ubiquitin ligases, atrogin-1 and MuRF1 are up-regulated in aged rat Tibialis Anterior muscle.

Authors:  Stephan Clavel; Anne-Sophie Coldefy; Emilie Kurkdjian; Jérôme Salles; Irène Margaritis; Benoît Derijard
Journal:  Mech Ageing Dev       Date:  2006-09-01       Impact factor: 5.432

2.  FoxO3 controls autophagy in skeletal muscle in vivo.

Authors:  Cristina Mammucari; Giulia Milan; Vanina Romanello; Eva Masiero; Ruediger Rudolf; Paola Del Piccolo; Steven J Burden; Raffaella Di Lisi; Claudia Sandri; Jinghui Zhao; Alfred L Goldberg; Stefano Schiaffino; Marco Sandri
Journal:  Cell Metab       Date:  2007-12       Impact factor: 27.287

3.  Basal muscle amino acid kinetics and protein synthesis in healthy young and older men.

Authors:  E Volpi; M Sheffield-Moore; B B Rasmussen; R R Wolfe
Journal:  JAMA       Date:  2001-09-12       Impact factor: 56.272

4.  Aerobic exercise overcomes the age-related insulin resistance of muscle protein metabolism by improving endothelial function and Akt/mammalian target of rapamycin signaling.

Authors:  Satoshi Fujita; Blake B Rasmussen; Jerson G Cadenas; Micah J Drummond; Erin L Glynn; Fred R Sattler; Elena Volpi
Journal:  Diabetes       Date:  2007-03-09       Impact factor: 9.461

5.  Identification of ubiquitin ligases required for skeletal muscle atrophy.

Authors:  S C Bodine; E Latres; S Baumhueter; V K Lai; L Nunez; B A Clarke; W T Poueymirou; F J Panaro; E Na; K Dharmarajan; Z Q Pan; D M Valenzuela; T M DeChiara; T N Stitt; G D Yancopoulos; D J Glass
Journal:  Science       Date:  2001-10-25       Impact factor: 47.728

6.  The healthcare costs of sarcopenia in the United States.

Authors:  Ian Janssen; Donald S Shepard; Peter T Katzmarzyk; Ronenn Roubenoff
Journal:  J Am Geriatr Soc       Date:  2004-01       Impact factor: 5.562

7.  Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy.

Authors:  Marco Sandri; Claudia Sandri; Alex Gilbert; Carsten Skurk; Elisa Calabria; Anne Picard; Kenneth Walsh; Stefano Schiaffino; Stewart H Lecker; Alfred L Goldberg
Journal:  Cell       Date:  2004-04-30       Impact factor: 41.582

8.  Akt promotes increased mammalian cell size by stimulating protein synthesis and inhibiting protein degradation.

Authors:  Jesika Faridi; Janet Fawcett; Lihong Wang; Richard A Roth
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-07-22       Impact factor: 4.310

9.  Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression.

Authors:  Stewart H Lecker; R Thomas Jagoe; Alexander Gilbert; Marcelo Gomes; Vickie Baracos; James Bailey; S Russ Price; William E Mitch; Alfred L Goldberg
Journal:  FASEB J       Date:  2004-01       Impact factor: 5.191

10.  FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells.

Authors:  Jinghui Zhao; Jeffrey J Brault; Andreas Schild; Peirang Cao; Marco Sandri; Stefano Schiaffino; Stewart H Lecker; Alfred L Goldberg
Journal:  Cell Metab       Date:  2007-12       Impact factor: 27.287

View more
  27 in total

Review 1.  Atrogin-1, MuRF-1, and sarcopenia.

Authors:  Jonathan P Gumucio; Christopher L Mendias
Journal:  Endocrine       Date:  2012-07-20       Impact factor: 3.633

2.  The clinical impact and biological mechanisms of skeletal muscle aging.

Authors:  Zaira Aversa; Xu Zhang; Roger A Fielding; Ian Lanza; Nathan K LeBrasseur
Journal:  Bone       Date:  2019-05-22       Impact factor: 4.398

Review 3.  Current understanding of sarcopenia: possible candidates modulating muscle mass.

Authors:  Kunihiro Sakuma; Wataru Aoi; Akihiko Yamaguchi
Journal:  Pflugers Arch       Date:  2014-05-07       Impact factor: 3.657

Review 4.  Molecular mechanism of sarcopenia and cachexia: recent research advances.

Authors:  Kunihiro Sakuma; Wataru Aoi; Akihiko Yamaguchi
Journal:  Pflugers Arch       Date:  2017-01-19       Impact factor: 3.657

Review 5.  Recent advances in pharmacological, hormonal, and nutritional intervention for sarcopenia.

Authors:  Kunihiro Sakuma; Akihiko Yamaguchi
Journal:  Pflugers Arch       Date:  2017-10-18       Impact factor: 3.657

6.  Hyperhomocysteinemia attenuates angiogenesis through reduction of HIF-1α and PGC-1α levels in muscle fibers during hindlimb ischemia.

Authors:  Sudhakar Veeranki; Srikanth Givvimani; Sathnur Pushpakumar; Suresh C Tyagi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-02-28       Impact factor: 4.733

Review 7.  Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1.

Authors:  Sue C Bodine; Leslie M Baehr
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-08-05       Impact factor: 4.310

8.  Absence of morphological and molecular correlates of sarcopenia in the macaque tongue muscle styloglossus.

Authors:  Alan J Sokoloff; Megan Douglas; Jill A Rahnert; Thomas Burkholder; Kirk A Easley; Qingwei Luo
Journal:  Exp Gerontol       Date:  2016-08-24       Impact factor: 4.032

Review 9.  Murine models of atrophy, cachexia, and sarcopenia in skeletal muscle.

Authors:  Mark Romanick; Ladora V Thompson; Holly M Brown-Borg
Journal:  Biochim Biophys Acta       Date:  2013-03-20

10.  Dysregulation of mitochondrial quality control processes contribute to sarcopenia in a mouse model of premature aging.

Authors:  Anna-Maria Joseph; Peter J Adhihetty; Nicholas R Wawrzyniak; Stephanie E Wohlgemuth; Anna Picca; Gregory C Kujoth; Tomas A Prolla; Christiaan Leeuwenburgh
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.